Steris Q4 EPS $2.83 and $1.59B Revenue Miss Estimates; Shares Dip
STE•STERIS reported Q4 adjusted EPS of $2.83 and revenues of $1.59 billion, both narrowly missing consensus estimates. Shares dipped in after-hours trading despite management’s optimistic outlook for fiscal 2027.
1. Q4 Financial Results
STERIS reported adjusted earnings per share of $2.83 on revenues of $1.59 billion for the fourth quarter, narrowly missing analyst forecasts. Despite the slight shortfall, results still reflected top-line growth compared with the prior year.
2. After-Hours Trading Reaction
Following the earnings release, STERIS shares declined in after-hours trading as investors reacted to the missed EPS and revenue figures. The move contrasted with broader market gains that day.
3. Fiscal 2027 Outlook
Management reaffirmed its fiscal 2027 guidance for mid-single-digit revenue growth and margin expansion, citing a healthy order backlog and strategic investments in service offerings.
